Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Schols

Showing results (1-10 of 392) with videos related to

Pageof 40
Sort By:
Current Opinion in HIV and AIDS|April 18, 2009
HIV coreceptor CXCR4 antagonistsDominique Schols
Current Topics in Medicinal Chemistry|May 12, 2004
HIV co-receptors as targets for antiviral therapyDominique Schols
Antiviral Research|June 7, 2006
HIV co-receptor inhibitors as novel class of anti-HIV drugsDominique Schols
Expert Opinion on Investigational Drugs|September 28, 2005
Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptorKurt Vermeire, Dominique Schols
The Journal of Antimicrobial Chemotherapy|June 28, 2005
Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugsKurt Vermeire, Dominique Schols
Cytokine & Growth Factor Reviews|July 12, 2005
HIV chemokine receptor inhibitors as novel anti-HIV drugsKatrien Princen, Dominique Schols
Marine Drugs|August 2, 2012
Algal lectins as potential HIV microbicide candidatesDana Huskens, Dominique Schols
Current HIV Research|January 24, 2012
Combination of antiretroviral drugs as microbicidesJan Balzarini, Dominique Schols
Journal of Leukocyte Biology|September 10, 2003
Specific CD4 down-modulating compounds with potent anti-HIV activityKurt Vermeire, Dominique Schols
Journal of Medicinal Chemistry|November 20, 2012
HIV-1 X4 activities of polycationic "viologen" based dendrimers by interaction with the chemokine receptor CXCR4: study of structure-activity relationshipSimona Asaftei, Dana Huskens, Dominique Schols
Pageof 40

Showing results (1-10 of 392) with videos related to

Sort By:
Pageof 40
Current Opinion in HIV and AIDS|April 18, 2009
HIV coreceptor CXCR4 antagonistsDominique Schols
Current Topics in Medicinal Chemistry|May 12, 2004
HIV co-receptors as targets for antiviral therapyDominique Schols
Antiviral Research|June 7, 2006
HIV co-receptor inhibitors as novel class of anti-HIV drugsDominique Schols
Expert Opinion on Investigational Drugs|September 28, 2005
Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptorKurt Vermeire, Dominique Schols
The Journal of Antimicrobial Chemotherapy|June 28, 2005
Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugsKurt Vermeire, Dominique Schols
Cytokine & Growth Factor Reviews|July 12, 2005
HIV chemokine receptor inhibitors as novel anti-HIV drugsKatrien Princen, Dominique Schols
Marine Drugs|August 2, 2012
Algal lectins as potential HIV microbicide candidatesDana Huskens, Dominique Schols
Current HIV Research|January 24, 2012
Combination of antiretroviral drugs as microbicidesJan Balzarini, Dominique Schols
Journal of Leukocyte Biology|September 10, 2003
Specific CD4 down-modulating compounds with potent anti-HIV activityKurt Vermeire, Dominique Schols
Journal of Medicinal Chemistry|November 20, 2012
HIV-1 X4 activities of polycationic "viologen" based dendrimers by interaction with the chemokine receptor CXCR4: study of structure-activity relationshipSimona Asaftei, Dana Huskens, Dominique Schols
Pageof 40